Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

DCC Approves RealTime Digital Portal to Track NDPS Regulated Pharma Products

Reduce price of 3 anti-cancer drugs: Govt asks manufacturers

Written By Ruchika Sharma29 Oct 2024 5:46 PM IST

New Delhi: To ensure the affordable availability of drugs, the government has asked the companies to reduce the prices of three anti-cancer drugs,...

Granules India packaging facility in US successfully completes USFDA inspection

Sai Life Sciences receives EIRs from USFDA for India RnD, Manufacturing facilities

Written By Ruchika Sharma29 Oct 2024 12:00 PM IST

Hyderabad: Sai Life Sciences, a Indian Contract Research, Development and Manufacturing Organization (CRDMO), has announced that it has...

Pharma, Healthcare Firms Set for 11% Growth in Q4, Margins Under Pressure: HDFC Securities

49 drugs samples including PAN 40, Calvam 625, Zerodol-SP Tablet fail to meet CDSCO quality test

Written By Ruchika Sharma28 Oct 2024 6:18 PM IST

New Delhi: In its latest drug alert, the Central Drug Standard Control Organization (CDSCO) has flagged forty-nine medicine batches for failing to...

Maharashtra Govt Seeks Rs 26.5 Crore for Track-and-Trace System

CDSCO declares 4 formulations as spurious including PAN D, SHELCAL 500

Written By Ruchika Sharma28 Oct 2024 6:00 PM IST

New Delhi: The Central Drug Standard Control Organisation (CDSCO) has issued a list of drugs, medical devices, vaccines, and cosmetics for the month...

Emcure Pharma Q3 Profit 48% to Rs 231 Cr

Emcure Pharma launches new dermatology-focused arm Emcutix Biopharma

Written By Ruchika Sharma28 Oct 2024 4:14 PM IST

Pune: Emcure Pharmaceuticals Limited, an Indian Pharma company, has launched a wholly-owned subsidiary, Emcutix Biopharmaceuticals...

Piramal Pharma deploying USD 85 million capex this fiscal: Nandini Piramal

Written By Ruchika Sharma28 Oct 2024 2:15 PM IST

New Delhi: A capex of about USD 85 million is being utilized by Mumbai-headquartered company, Piramal Pharma, for various initiatives, including...

No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUN

Sun Pharma presents Leqselvi data highlighting clinical efficacy, durability for Alopecia Areata treatment at 2024 Fall Clinical Dermatology Conference

Written By Ruchika Sharma28 Oct 2024 11:30 AM IST

Mumbai: Sun Pharmaceutical Industries Limited has presented new data highlighting the clinical efficacy and safety of LEQSELVI (deuruxolitinib) 8...

MSD Phase 3 trial of head and neck cancer treatment meets primary endpoint

Written By Ruchika Sharma13 Oct 2024 10:00 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA...

Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America

Alkem Labs inks pact with Sonnet BioTherapeutics to develop, commercialise drug candidate for diabetic peripheral neuropathy in India

Written By Ruchika Sharma12 Oct 2024 11:00 AM IST

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to develop, manufacture and...

Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy Pipeline

Switzerland COMCO competition commission terminates Novartis probe without consequences

Written By Ruchika Sharma11 Oct 2024 12:30 PM IST

Berlin: Switzerland's COMCO competition commission said on Thursday that it has terminated a probe against Novartis into possibly using blocking...

Govt extends deadline for submitting applications under PLI Scheme

Akums unveils Dual-Action Heartburn Relief Chewable Tablets for India

Written By Ruchika Sharma11 Oct 2024 11:30 AM IST

New Delhi: Akums Drugs and Pharmaceuticals has introduced dual-action heartburn relief chewable tablet, combining Famotidine, Calcium Carbonate, and...

EU gives marketing authorization for Novavax updated 2024-2025 Nuvaxovid COVID vaccine

Written By Ruchika Sharma11 Oct 2024 10:00 AM IST

Gaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, has announced that the European...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok